Apollo to Buy Minority Stake in CH2M Hill
Apollo Global Management has agreed to buy a minority stake in
CH2M Hill, a deal that values the global engineering services
company at roughly $2 billion.
Sunac Drops Kaisa Takeover Plan
China's Sunac said it is terminating its takeover attempt of
Kaisa Group, a struggling property developer that defaulted on its
loans and bond payments earlier this year.
Broadcom in $35 Billion Merger Talks
Chip maker Broadcom is in advanced talks to be bought by rival
Avago Technologies in a deal worth more than $35 billion, the
latest in a recent string of mergers in the semiconductor
industry.
U.S. Seeks Details on Top China Official Amid Bank-Hiring
Probe
The SEC is seeking information about a Chinese anticorruption
official in connection with its probe of J.P. Morgan's hiring of
relatives of Chinese government officials.
Corruption Allegations Reach Into Soccer's Highest Levels
Prosecutors alleged that senior officials of FIFA got more than
$150 million in bribes and kickbacks as part of a sprawling scheme
that functioned like a criminal enterprise.
Liquidators of Ex-Harvard QB's Funds Sue Barclays for $80
Million
The liquidators of a pair of failed Cayman Islands-based hedge
funds run by a former Harvard quarterback are suing Barclays PLC to
claw back some $80 million they say was illegally funneled to the
bank to cover margin calls.
Wal-Mart Settles With Tracy Morgan
Wal-Mart Stores Inc. has a reached a settlement with "30 Rock"
star Tracy Morgan and other plaintiffs who were injured in a June
2014 crash on the New Jersey Turnpike.
J.P. Morgan Sees Losing Some Business Due to FX Guilty Plea
J.P. Morgan Chief James Dimon said the bank's recent foreign
exchange guilty plea didn't cripple the bank, but it was a scary
outcome that will probably cost it some business.
Teva Reports Small Stake in Mylan
Teva Pharmaceutical, which is seeking to buy rival Mylan,
disclosed a 1.35% stake in the generic-drug maker.
Popeyes Profit Rises, Full-Year Projections Up
Popeyes Louisiana Kitchen's first-quarter profit rose as the
fast-food chain reported higher sales and continued market-share
gains.
Lockheed Martin Open to Deals, Mum On Sikorsky
The head of Lockheed Martin declined to comment on whether the
company was interested in buying all or part of helicopter supplier
Sikorsky Aircraft.
Airbus Asks Chief Executive to Stay for Another Term
Airbus Group NV Chairman Denis Ranque told shareholders on
Wednesday the board has asked Chief Executive Tom Enders to remain
in the post for another term. His mandate was due to expire in
2016.
Union Pacific Moves to Offset Lower Cargo Volumes
Union Pacific Corp. has mothballed more locomotives and
furloughed additional employees, as its transport volumes run 4%
lower so far this quarter, compared with a 2% dip in the first
quarter.
Google's Search for Platforms on Display
Google this week will make a renewed push for developers to work
with Android for wearable devices, Internet-connected TVs, cars and
virtual reality at its I/O conference.
Bids Fly as GE Unit Auction Nears an End
Several private-equity firms are vying to buy General Electric
Co.'s unit that funds leveraged buyouts, in a sale process that
could fetch more than $17 billion for GE and be the largest U.S.
finance deal since the financial crisis.
Semtech Results Hurt by Smartphone Customer Demand
Semtech Corp. said demand from its largest smartphone customer
was much lower than expected in the April quarter, and it projected
results below Wall Street views for the current quarter.
Ocwen's Houston Site to End Residential-Servicing
Ocwen Financial said its Houston facility will discontinue
residential-servicing operations, affecting about 140 jobs.
FBI Investigating Hysterectomy Tool
The morcellator surgical tool was found to spread uterine
cancer, and the FBI is examining what the largest maker of it,
Johnson & Johnson, knew about its hazards.
FDA Clears Two Irritable Bowel Syndrome Treatments
The U.S. Food and Drug Administration has cleared two treatments
for irritable bowel syndrome with diarrhea, approving drugs that
are both linked to recent merger activity in the sector.